These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323 [TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin. Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495 [TBL] [Abstract][Full Text] [Related]
7. Is It Possible to Intervene in the Capacity of Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A Front Immunol; 2021; 12():789145. PubMed ID: 34975884 [TBL] [Abstract][Full Text] [Related]
8. Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression. González A; Härtel S; Mansilla J; Sánchez-Valdéz F; Ferreira A Immunobiology; 2018 Dec; 223(12):802-806. PubMed ID: 30131175 [TBL] [Abstract][Full Text] [Related]
10. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta. Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234 [TBL] [Abstract][Full Text] [Related]
11. Ramírez-Toloza G; Ferreira A Front Microbiol; 2017; 8():1667. PubMed ID: 28919885 [TBL] [Abstract][Full Text] [Related]
12. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth. Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898 [TBL] [Abstract][Full Text] [Related]
14. In vitro Treatment of a Murine Mammary Adenocarcinoma Cell Line with Recombinant Trypanosoma cruzi Calreticulin Promotes Immunogenicity and Phagocytosis. Sosoniuk-Roche E; Cruz P; Maldonado I; Duaso L; Pesce B; Michalak M; Valck C; Ferreira A Mol Immunol; 2020 Aug; 124():51-60. PubMed ID: 32526557 [TBL] [Abstract][Full Text] [Related]
15. Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process. Wyllie MP; Ramirez MI Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28859399 [TBL] [Abstract][Full Text] [Related]
18. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge. Sánchez-Valdéz FJ; Pérez Brandán C; Ramírez G; Uncos AD; Zago MP; Cimino RO; Cardozo RM; Marco JD; Ferreira A; Basombrío MÁ PLoS Negl Trop Dis; 2014 Feb; 8(2):e2696. PubMed ID: 24551259 [TBL] [Abstract][Full Text] [Related]
19. Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin? Ramírez-Toloza G; Abello P; Ferreira A Front Immunol; 2016; 7():268. PubMed ID: 27462315 [TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis. Sánchez Valdéz FJ; Pérez Brandán C; Zago MP; Labriola C; Ferreira A; Basombrío MÁ Mol Immunol; 2013 Mar; 53(3):198-205. PubMed ID: 22954747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]